Lack of correlation between peripheral blood lymphokine-activated killer (lak) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2-Reference-Cited by-同舟云学术

Lack of correlation between peripheral blood lymphokine-activated killer (lak) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2

Published:1989-03-15 Issue:3 Volume:43 Page:410-414
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ghosh A. K.,Dazzi H.,Thatcher N.,Moore M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference33 articles.

1. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

2. , and , Recombinant interleukin 2 (rIL-2) given intrasplenically and intravenously for advanced malignant melanoma. A phase I/II study. Proceedings ECCO-4. 4th European Conference on Clinical Oncology and Cancer Nursing, Madrid. Abstract 372, p. 99, Fundación para la Investigación y la Formacion en Oncologià, Madrid (1987).

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I;European Journal of Immunology;2006-09

2. The intriguing role of polymorphonuclear neutrophils in antitumor reactions;Blood;2001-01-15

3. Cytokines Secreted by Lymphokine-Activated Killer Cells Induce Endogenous Nitric Oxide Synthesis and Apoptosis in DLD-1 Colon Cancer Cells;Cellular Immunology;2000-08

4. The Prehistory and History of the Uses of Interleukin-2 in Cancer Therapy;Interferon: The Dawn of Recombinant Protein Drugs;1999

5. Neutrophil activation, vascular leak toxicity, and cytolysis during interleukin-2 infusion in human cancer;Surgery;1997-11